Back to Search
Start Over
Undiagnosed cardiovascular risk factors including elevated lipoprotein(a) in patients with ischaemic heart disease.
- Source :
-
Frontiers in epidemiology [Front Epidemiol] 2023 Jul 17; Vol. 3, pp. 1207752. Date of Electronic Publication: 2023 Jul 17 (Print Publication: 2023). - Publication Year :
- 2023
-
Abstract
- Objectives: This study aims to investigate the prevalence of undiagnosed cardiovascular risk factors in patients with ischaemic heart disease (IHD).<br />Methods: We assessed the prevalence of previously undiagnosed cardiovascular risk factors, including elevated lipoprotein(a) [Lp(a)], among consenting patients with IHD who were admitted to hospital. Clinical information, including dietary history, from patients with newly diagnosed IHD and known IHD were compared.<br />Results: Of the 555 patients, 82.3% were males and 48.5% of Chinese ethnicity. Overall, 13.3% were newly diagnosed with hypertension, 14.8% with hypercholesterolemia, and 5% with type 2 diabetes (T2DM). Patients with newly diagnosed IHD, compared to those with known IHD, had a higher prevalence of new diagnoses of hypercholesterolemia (29.1% vs. 2.0%, p < 0.001), hypertension (24.5% vs. 3.4%, p < 0.001) and T2DM (7.3% vs. 3.1%, p = 0.023). Active smoking was prevalent in 28.3% of patients, and higher in newly diagnosed IHD (34.1% vs. 23.2%, p = 0.005). Elevated Lp(a) of ≥120 nmol/L was detected in 15.6% of all patients, none of whom were previously diagnosed. Dietary habits of >50% of patients in both groups did not meet national recommendations for fruits, vegetables, wholegrain and oily fish intake. However, patients with known IHD had a more regular omega-3 supplement intake (23.4% vs. 10.3%, p = 0.024).<br />Conclusion: Increased detection efforts is necessary to diagnose chronic metabolic diseases (hypertension, hypercholesterolemia, T2DM) especially among patients at high risk for IHD. Cardiovascular risk factors, in particular elevated Lp(a), smoking, and suboptimal dietary intake in patients with IHD deserve further attention.<br />Competing Interests: The author TP declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.<br /> (© 2023 Chua, Lam, Mak, Lee, Dacay, Yew, Puar, Khoo, Chow, Tan, Tong, Liew, Yeo and Loh.)
Details
- Language :
- English
- ISSN :
- 2674-1199
- Volume :
- 3
- Database :
- MEDLINE
- Journal :
- Frontiers in epidemiology
- Publication Type :
- Academic Journal
- Accession number :
- 38455910
- Full Text :
- https://doi.org/10.3389/fepid.2023.1207752